As Countries Worldwide Face Shortages – Appeal for Equitable COVID-19 Vaccine Access on World Health Day 06/04/2021 Kerry Cullinan Some of the world’s smallest countries joined the World Health Organization (WHO) to appeal for equitable access to COVID-19 vaccines on the eve of World Health Day – as the pipeline of global vaccine supplies to low- and middle-income countries risk drying up for the coming few months. Barbados Prime Minister Mia Amor Mottley told […] Continue reading -> Uganda Green Lights Private Imports Of COVID-19 Vaccines – Kenya Nixes Similar Initiative 06/04/2021 Esther Nakkazi In what may be a first for the African continent, the Ugandan government has decided to allow private sector health providers to import and distribute their own COVID-19 vaccines amidst strict regulations – in an effort to expedite the country’s vaccination drive, which is caught in the crosswinds of vaccine supply shortages plaguing the entire […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
Uganda Green Lights Private Imports Of COVID-19 Vaccines – Kenya Nixes Similar Initiative 06/04/2021 Esther Nakkazi In what may be a first for the African continent, the Ugandan government has decided to allow private sector health providers to import and distribute their own COVID-19 vaccines amidst strict regulations – in an effort to expedite the country’s vaccination drive, which is caught in the crosswinds of vaccine supply shortages plaguing the entire […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
Mayors Appeal for Equitable Access to Vaccines – Independent Panel calls for contributions ahead of WHO submission 19/03/2021 Kerry Cullinan Mayors from three capital cities in the global south have appealed for speedy “technology transfer” to enable them to produce their own COVID-19 vaccines at Friday’s World Health Organization (WHO) bi-weekly COVID-19 media briefing. The mayors’ appeal comes on the eve of a meeting next week between WHO Director General Dr Tedros Adhanom Ghebreyesus and […] Continue reading -> Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
Papua New Guinea Facing “Uncontrolled” COVID Outbreak – MSF Claims Australia’s Opposition To COVID Patent Waiver Hinders Vaccine Access By Pacific Island Neighbors 18/03/2021 Madeleine Hoecklin Papua New Guinea (PNG), a country that has largely avoided the SARS-CoV2 virus, is now facing an outbreak that could cause the country’s health system to collapse, while Australia is being chided by a Médecins Sans Frontières (MSF) official for its opposition to a World Trade Organization (WTO) patent waiver that MSF says would have opened […] Continue reading -> Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
Delayed Delivery Of Vaccines Procured By Africa CDC Threatens Timeline For Achieving ‘Herd Immunity’ 17/03/2021 Paul Adepoju Africa’s goal of achieving herd immunity against COVID-19 hangs in the balance as 270 million doses of vaccines are yet to arrive in the continent despite being secured three months ago by the African Union (AU) and African Centres for Diseae Control (ACDC). Mid-January 2021, Health Policy Watch reported that the Africa CDC had […] Continue reading -> South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
South Africa Vaccine Rollout: Health Worker Jabs Inch Forward – But With Insufficient Doses For Everyone 17/03/2021 Kerry Cullinan South Africa’s vaccination programme for health workers is inching forward, fuelled by small deliveries of the Johnson & Johnson vaccine every two weeks. However, overall supplies remain far short of the needs – even for the health sector. The country has an estimated 1.25 million health workers in public and private health to serve its […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts
Novavax Vaccine Shows Less Efficacy Against COVID Variants – Sputnik Vaccine to Be Produced In Italy 14/03/2021 Madeleine Hoecklin Novavax’s COVID-19 vaccine candidate has an efficacy rate of 96.4% against the original strain of SARS-CoV2. However, the efficacy rate drops up to 55.4% against the new B.1351 variant first identified in South Africa, and also spreading globally. The pharma company, which has never brought a vaccine to market before, published the data from two […] Continue reading -> Posts navigation Older postsNewer posts